Transgene : Inside Information / Other news releases
PRESS RELEASE Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio ... | May 5, 2023
Stay updated with breaking news from Intima Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRESS RELEASE Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio ... | May 5, 2023
Investegate announcements from MaxCyte, Inc., Preliminary Unaudited Q4 &FY 2022 Revenue Results
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
MXCT earnings call for the period ending March 31, 2022.